Financials
- Market Capitalization 2.12 B
- Employee 975
- Founded 2007
- CEO N/A
- Website www.iovance.com
- Headquarter Delaware, United States
- FIGI BBG000FTLBV7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
0.03
Relación precio/flujo de caja
0.01
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1917 | BHVN Biohaven Ltd. Common Shares | 14.87 USD | -0.47% | -9.71% | +12.99% | -12.23% | 2.24 B USD | ||
| 1926 | OCUL Ocular Therapeutix, Inc. - Common Stock | 9.96 USD | +2.68% | -1.97% | +8.73% | -13.39% | 2.18 B USD | ||
| 1962 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 23.52 USD | -2.53% | -5.05% | +25.98% | +154.00% | 2.08 B USD | ||
| 1968 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.10 USD | +0.75% | -1.77% | -0.74% | +34.95% | 2.07 B USD |